Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Non-Current Deferred Tax Liability (2022 - 2025)

Century Therapeutics (IPSC) has disclosed Non-Current Deferred Tax Liability for 3 consecutive years, with $4.3 million as the latest value for Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability fell 1.67% to $4.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.3 million through Dec 2025, down 1.67% year-over-year, with the annual reading at $4.3 million for FY2025, 1.67% down from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2025 was $4.3 million at Century Therapeutics, down from $4.4 million in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $4.4 million in Q4 2024, with the low at $5000.0 in Q4 2022.
  • Average Non-Current Deferred Tax Liability over 3 years is $3.6 million, with a median of $4.3 million recorded in 2024.
  • Peak annual rise in Non-Current Deferred Tax Liability hit 29.95% in 2025, while the deepest fall reached 1.67% in 2025.
  • Over 3 years, Non-Current Deferred Tax Liability stood at $5000.0 in 2022, then soared by 87380.0% to $4.4 million in 2024, then fell by 1.67% to $4.3 million in 2025.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods came in at $4.3 million, $4.4 million, and $4.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.